Si kosmeta, MB - financials and debts

Company age: 2 y. 6 mo.

Update

Si kosmeta - Company finances

EUR
2024
From: 2024-03-14
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 7,302 14,422
Profit before tax 1,291 67
Net profit 1,291 64
Equity 1,292 1,356
Liabilities 733 3
Non-current assets 21,267 12,468
Current assets 2,025 1,358
Total assets 23,292 13,826
Taxes paid
STI taxes 846 -
Financial indicators
Revenue change y/y - +97.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 5.5% 0.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 99.9% 4.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 17.7% 0.4%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 17.7% 0.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.6 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Si kosmeta - Social security debts

From To Debt, €
2026-06-22 2026-06-30 9.12
2026-06-11 2026-06-21 3.19
2026-06-08 2026-06-10 40.31
2026-03-03 2026-03-31 52.27
2026-02-13 2026-02-28 11.96
2025-10-01 2025-10-31 36.30
2025-08-04 2025-08-31 36.30
2025-06-03 2025-07-31 36.30
2025-05-04 2025-05-31 36.30
2025-04-07 2025-04-30 36.30
2025-03-04 2025-03-31 36.30
2024-07-02 2024-07-31 64.50

Si kosmeta - VMI tax arrears

From To Overdue, €
2025-02-27 2025-02-28 61.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Si kosmeta, MB (code 306702102) is a Small partnership operating in other human health activities n.e.c. In the latest financial year, 2025, the company generated revenue of €14.4K and net profit of €64, resulting in a profit margin of 0.4%. Revenue increased by 97.5% year on year from €7.3K in 2024, showing a strong expansion in turnover, although profitability weakened materially compared with the prior year. In 2024, net profit was €1.3K and the margin was 17.7%, while 2025 profit remained positive but at a much lower level. The balance sheet shows total assets of €13.8K in 2025, down from €23.3K in 2024, with equity at €1.4K and liabilities at only €3. Most assets were long-term assets, amounting to €12.5K, while short-term assets were €1.4K. Key ratios for 2025 indicate return on equity of 4.7%, return on assets of 0.5%, and asset turnover of 1.04x. The figures point to a small business with rising revenue, limited leverage, and very modest absolute earnings.